Benjamin Hohl, CFO: Enliven Therapeutics ELVN Planned sale · Filed 06/17

Trade details

Type: Planned sale notice
Stock: Enliven Therapeutics ELVN
Person: Benjamin HohlCFO
Planned sale date: 26/06/17
Filed: 26/06/17

$768.2K to be sold

Enliven Therapeutics trades, last 26 weeks

What else happened in Enliven Therapeutics around then

Filed or reported within 30 days of the trade day · 05/18~07/17

Benjamin Hohl's recent trades

Benjamin HohlCFO
Planned sale10b5-1 planEnliven Therapeutics
Planned sale10b5-1 plan
Enliven Therapeutics
ELVN
$591.2K
12,036 sh
$591.2K
Filed 09/17
Traded 09/17
Benjamin HohlCFO
Sell10b5-1 planEnliven Therapeutics
Sell10b5-1 plan
Enliven Therapeutics
ELVN
$149.2K
3,401 sh
$149.2K
Filed 06/22
Traded 06/17
Benjamin HohlCFO
Sell10b5-1 planEnliven Therapeutics
Sell10b5-1 plan
Enliven Therapeutics
ELVN
$59K
1,379 sh
$59K
Filed 06/22
Traded 06/17
Benjamin HohlCFO
Sell10b5-1 planEnliven Therapeutics
Sell10b5-1 plan
Enliven Therapeutics
ELVN
$55.4K
1,238 sh
$55.4K
Filed 06/22
Traded 06/17
Benjamin HohlCFO
SellEnliven Therapeutics
Sell
Enliven Therapeutics
ELVN
$295.8K
10,000 sh
$295.8K
Filed 03/10
Traded 03/06

Benjamin Hohl, CFO — plans to sell 18,054 sh of Enliven Therapeutics ELVN · $768.2K · around 06/17 · 10b5-1 plan | Whalegun